heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with repaglinide in 1 studies
| Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Studies (repaglinide) | Trials (repaglinide) | Recent Studies (post-2010) (repaglinide) |
|---|---|---|---|---|---|
| 148 | 0 | 45 | 610 | 152 | 244 |
| Protein | Taxonomy | heptakis(2,6-o-dimethyl)beta-cyclodextrin (IC50) | repaglinide (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 9.2 | |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | 9.2 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y; Li, C | 1 |
1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and repaglinide
| Article | Year |
|---|---|
Analysis of repaglinide enantiomers in pharmaceutical formulations by capillary electrophoresis using 2,6-di-o-methyl-β-cyclodextrin as a chiral selector.
Topics: beta-Cyclodextrins; Carbamates; Drug Contamination; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Limit of Detection; Linear Models; Piperidines; Reproducibility of Results; Stereoisomerism; Tablets | 2012 |